The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 03, 2015

Filed:

May. 26, 2011
Applicants:

John Emmerson Campbell, Cambridge, MA (US);

Michael Charles Hewitt, Somerville, MA (US);

Philip Jones, Danvers, MA (US);

Linghong Xie, Southborough, MA (US);

Inventors:

John Emmerson Campbell, Cambridge, MA (US);

Michael Charles Hewitt, Somerville, MA (US);

Philip Jones, Danvers, MA (US);

Linghong Xie, Southborough, MA (US);

Assignee:

Sunovion Pharmaceuticals Inc., Marlborough, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/498 (2006.01); C07D 241/40 (2006.01); C07D 403/06 (2006.01); C07D 401/06 (2006.01); C07D 471/04 (2006.01); C07D 471/14 (2006.01); C07D 487/04 (2006.01); C07D 491/056 (2006.01); C07D 498/14 (2006.01); C07D 519/00 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 409/06 (2006.01); C07D 409/14 (2006.01); C07D 413/06 (2006.01); C07D 417/06 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 403/06 (2013.01); C07D 401/06 (2013.01); C07D 471/04 (2013.01); C07D 471/14 (2013.01); C07D 487/04 (2013.01); C07D 491/056 (2013.01); C07D 498/14 (2013.01); C07D 519/00 (2013.01); C07D 401/14 (2013.01); C07D 405/14 (2013.01); C07D 409/06 (2013.01); C07D 409/14 (2013.01); C07D 413/06 (2013.01); C07D 417/06 (2013.01); C07D 498/04 (2013.01);
Abstract

Provided herein are compounds of formula A-L-B, and pharmaceutically acceptable salts and stereoisomers thereof, wherein A is Rand Rtogether with the carbon atoms to which they are attached form a 1,2-phenylene ring optionally substituted with one or more R; L is —C(R)—C(R)—; B is a heteroaromatic group defined herein; and -A-A- , A, Rand Rare defined herein. Also disclosed are methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.


Find Patent Forward Citations

Loading…